Over the past two decades, U.S. small cap stocks have outperformed large-cap stocks, and the same could be true for 2022 as well, according to Goldman Sachs. To give an idea of the returns that you can generate from small-cap stocks in the short-term, discussed below are the ten best performing small-cap stocks in March 2022.
We have used the March return data (from finviz.com) to make the ranking. Here they are, in reverse order.
10 Polymet Mining (61%)
Founded in 1981 and headquartered in St. Paul, Minn., this company explores and develops natural resource properties. Polymet Mining Corp (NYSE:PLM) shares are up almost 56% year-to-date and over 22% in the last one year. Its shares are currently trading over $3.70, while it has a 52-week range of $2.41 and $4.79. As of writing, it had a market cap of over $390 million.
9. Cenntro Electric Group (67%)
Cenntro Electric Group Ltd (NASDAQ:CENN) designs and makes electric light and medium duty commercial vehicles. Founded in 2017 and headquartered in Freehold, N.J., Cenntro Electric comprises the following brands: Neibor, Logistar, Cenntro, Metro, and Terramak. CENN shares are down over 63% year-to-date and over 70% in the last one year. Its shares are currently trading over $1.90, while it has a 52-week range of $1.05 and $15. As of writing, it had a market cap of over $520 million.
8. Aerovate Therapeutics (76%)
Aerovate Therapeutics Inc (NASDAQ:AVTE) is a clinical-stage biopharmaceutical company that develops drugs to enhance the lives of patients with rare cardiopulmonary diseases. Shares of the company, founded in 2018 and headquartered in Waltham, Mass., are up almost 40% year-to-date. At time of writing, AVTE is trading over $16.40, while it has a 52-week range of $7.74 and $29.43. The company has a market cap of over $395 million.
7. Cutera (77%)
Founded in 1998 and headquartered in Brisbane, Calif., Cutera (NASDAQ:CUTR) deals in laser and energy-based aesthetic systems for practitioners and is comprised of the following segments: Asia excluding Japan, Japan, Europe, United States and the Rest of the World. CUTR shares are up almost 58% year-to-date and almost 108% in the last one year. Its shares are currently trading over $65, while it has a 52-week range of $27.27 and $74.38.
6. GreenLight Biosciences Holdings PBC (81%)
A biotechnology company that develops ribonucleic acid (RNA) products for human therapies and agriculture, Greenlight Biosciences Holdings PBC (NASDAQ:GRNA) was founded in 2008 and is headquartered in Medford, Mass., Greenlight Biosciences shares are down almost 10% year-to-date and almost 9% in the last one year. GRNA shares are currently trading over $8.40, while it has a 52-week range of $4.83 and $15.80. As of writing, it had a market cap of more than $1.10 billion.
5. Owlet (82%)
Owlet (NYSE:OWLT), founded in 2012 and headquartered in Lehi, Utah, is a digital parenting platform that provides real-time data and insights to parents. Its products include Smart Sock, Dream Sock and more. OWLT shares are up almost 68% year-to-date but are down over 55% in the last one year; they are currently trading over $4.40, while it has a 52-week range of $1.5850 and $11.4250. As of writing, it had a market cap of more than $470 million.
4. NextDecade (88%)
Founded in 2010 and headquartered in Houston, Nextdecade (NASDAQ:NEXT) is a clean energy company that focuses on LNG export projects and associated pipelines. NEXT shares are up over 117% year-to-date and over 146% in the last one year. They are currently trading over $6, while it has a 52-week range of $1.84 and $7.81.
3. Target Hospitality (91%)
Target Hospitality (NASDAQ:TH) offers rental accommodations with premium catering, as well as value-added hospitality services. Founded in 1978 and headquartered in The Woodlands, Texas, TH shares are up over 56% year-to-date and almost 78% in the last one year and are currently trading over $5.50. TH shares have a 52-week range of $2.23 and $6.35.
2. Longeveron (99%)
Longeveron LLC (NASDAQ:LGVN) is a biotechnology company that develops cellular therapies for specific aging-related and life-threatening conditions. Shares of the 2014 founded, Miami, FL-headquarted company are down almost 13% year-to-date, but are up over 55% in the last one year. LGVN shares are currently trading over $10.30, while it has a 52-week range of $2.84 and $45.
1. Fulcrum Therapeutics Fulcrum (113%)
Founded in 2015 and headquartered in Cambridge, Mass., Fulcrum Therapeutics (NASDAQ:FULC) is a clinical stage biopharmaceutical company that focuses on unlocking gene control mechanisms to develop small molecule therapies. FULC shares are up over 29% year-to-date and over 92% in the last one year; currently trading over $22.80, while it has a 52-week range of $6.85 and $33.10.